Back
Palisade Bio, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
50
PALI
Palisade Bio, Inc.
Last Price:
$1.99
Seasonality Move:
-0.03%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
The current trend is moderately bullish and PALI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Palisade Bio, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.14 | Sell |
| 20-day SMA: | 2.03 | Sell |
| 50-day SMA: | 1.99 | Buy |
| 200-day SMA: | 1.15 | Buy |
| 8-day EMA: | 2 | Sell |
| 20-day EMA: | 1.61 | Buy |
| 50-day EMA: | 0.93 | Buy |
| 200-day EMA: | 0.29 | Buy |
Palisade Bio, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.48 | Buy |
| Relative Strength Index (14 RSI): | 48.57 | Sell |
| Chaikin Money Flow: | 3175494 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.76 - 2.2) | Buy |
| Bollinger Bands (100): | (0.93 - 2.15) | Buy |
Palisade Bio, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Palisade Bio, Inc. Stock
Is Palisade Bio, Inc. Stock a Buy?
-
Palisade Bio, Inc. share price is 1.99 while PALI 8-day simple moving average is 2.14, which is a Sell signal.
-
The stock price of PALI is 1.99 while Palisade Bio, Inc. 20-day SMA is 2.03, which makes it a Sell.
-
Palisade Bio, Inc. 50-day simple moving average is 1.99 while PALI share price is 1.99, making it a Buy technically.
-
PALI stock price is 1.99 and Palisade Bio, Inc. 200-day simple moving average is 1.15, creating a Buy signal.
PALI Technical Analysis vs Fundamental Analysis
Sell
50
Palisade Bio, Inc. (PALI)
is a Sell
Is Palisade Bio, Inc. a Buy or a Sell?
-
Palisade Bio, Inc. stock is rated a SellThe current Palisade Bio, Inc. [PALI] share price is $1.99. The Score for PALI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Palisade Bio, Inc. Stock Info
Market Cap:
296.9M
Price in USD:
1.99
Share Volume:
6M
Palisade Bio, Inc. 52-Week Range
52-Week High:
2.64
52-Week Low:
0.53
Sell
50
Palisade Bio, Inc. (PALI)
is a Sell
Palisade Bio, Inc. Share Price Forecast
-
What is the Palisade Bio, Inc. stock price today?The Palisade Bio, Inc. stock price is 1.99 USD today.
-
Will PALI stock go up or go down?Palisade Bio, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Palisade Bio, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Palisade Bio, Inc. is overvalued.
Is Palisade Bio, Inc. Stock a Buy?
-
Palisade Bio, Inc. share price is 1.99 while PALI 8-day exponential moving average is 2.00, which is a Sell signal.
-
The stock price of PALI is 1.99 while Palisade Bio, Inc. 20-day EMA is 1.61, which makes it a Buy.
-
Palisade Bio, Inc. 50-day exponential moving average is 0.93 while PALI share price is 1.99, making it a Buy technically.
-
PALI stock price is 1.99 and Palisade Bio, Inc. 200-day simple moving average is 0.29, creating a Buy signal.
Fundamental Analysis of Palisade Bio, Inc.
Is Palisade Bio, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Palisade Bio, Inc.
Should I short Palisade Bio, Inc. stock?
-
PALI Moving Average Covergence Divergence (MACD) indicator is 0.48, suggesting Palisade Bio, Inc. is a Buy
-
Palisade Bio, Inc. Relative Strength Index (RSI) is 48.57, which suggest Palisade Bio, Inc. is oversold
-
The Bollinger Bands (25) for Palisade Bio, Inc. is (1.76 - 2.2), which suggest Palisade Bio, Inc. is a Buy
-
The Bollinger Bands (100) for Palisade Bio, Inc. is (0.93 - 2.15), which suggest Palisade Bio, Inc. is a Buy
* Palisade Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.